BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19834056)

  • 1. Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.
    Wilson S; Hashamiyan S; Clarke L; Saftig P; Mort J; Dejica VM; Brömme D
    Am J Pathol; 2009 Nov; 175(5):2053-62. PubMed ID: 19834056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.
    Wilson S; Brömme D
    J Pediatr Rehabil Med; 2010; 3(2):139-46. PubMed ID: 21629671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
    Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
    Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates.
    Li Z; Hou WS; Brömme D
    Biochemistry; 2000 Jan; 39(3):529-36. PubMed ID: 10642177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
    Wilson SR; Peters C; Saftig P; Brömme D
    J Biol Chem; 2009 Jan; 284(4):2584-92. PubMed ID: 19028686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of collagenase activities of human cathepsins by glycosaminoglycans.
    Li Z; Yasuda Y; Li W; Bogyo M; Katz N; Gordon RE; Fields GB; Brömme D
    J Biol Chem; 2004 Feb; 279(7):5470-9. PubMed ID: 14645229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover.
    Pohl S; Angermann A; Jeschke A; Hendrickx G; Yorgan TA; Makrypidi-Fraune G; Steigert A; Kuehn SC; Rolvien T; Schweizer M; Koehne T; Neven M; Winter O; Velho RV; Albers J; Streichert T; Pestka JM; Baldauf C; Breyer S; Stuecker R; Muschol N; Cox TM; Saftig P; Paganini C; Rossi A; Amling M; Braulke T; Schinke T
    J Bone Miner Res; 2018 Dec; 33(12):2186-2201. PubMed ID: 30075049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity.
    Baldo G; Tavares AM; Gonzalez E; Poletto E; Mayer FQ; Matte UD; Giugliani R
    Cardiovasc Pathol; 2017; 27():45-50. PubMed ID: 28104572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
    Yamazaki H; Sasaki T
    J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cathepsin K deficiency on airway development and TGF-β1 degradation.
    Zhang D; Leung N; Weber E; Saftig P; Brömme D
    Respir Res; 2011 May; 12(1):72. PubMed ID: 21627832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.
    do Nascimento CC; Aguiar O; Viana GM; D Almeida V
    Reprod Fertil Dev; 2020 Feb; 32(3):304-312. PubMed ID: 31679559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
    Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
    Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.
    Zhu G; Chen W; Tang CY; McVicar A; Edwards D; Wang J; McConnell M; Yang S; Li Y; Chang Z; Li YP
    Int J Biol Sci; 2022; 18(14):5522-5538. PubMed ID: 36147479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel roles of glycosaminoglycans in the degradation of type I collagen by cathepsin K.
    Tatara Y; Suto S; Itoh K
    Glycobiology; 2017 Dec; 27(12):1089-1098. PubMed ID: 29029096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease.
    Monroy MA; Ross FP; Teitelbaum SL; Sands MS
    Bone; 2002 Feb; 30(2):352-9. PubMed ID: 11856642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models.
    Kingma SD; Wagemans T; IJlst L; Wijburg FA; van Vlies N
    J Inherit Metab Dis; 2014 Sep; 37(5):813-21. PubMed ID: 24699889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.